Perioperative & Surgical Care
Thyroidectomy complications: hypocalcemia and nerve injury
— Transient hypocalcemia: 20–30% after total thyroidectomy
— Permanent hypoparathyroidism (>6 months): 1–3%
— Transient RLN paresis: 3–8%
— Permanent RLN injury: <1–2% in high-volume centers, higher in reoperative or cancer surgery
— Postoperative neck hematoma: ~1%, but life-threatening
— Perioral or fingertip paresthesias, carpopedal spasm → hypocalcemia
— Hoarseness, breathy voice, weak cough, aspiration on thin liquids → unilateral RLN injury
— Stridor, biphasic noisy breathing, respiratory distress at extubation → bilateral RLN injury (airway emergency)
— Voice fatigue, loss of high pitch (singers, teachers) → EBSLN injury
— Expanding neck swelling, tracheal deviation, tense incision → hematoma
— Total (vs hemi-) thyroidectomy, central neck dissection, Graves disease, large substernal goiter, malignancy with extrathyroidal extension, reoperation, low-volume surgeon

— Onset typically 24–72 hours postop, but can appear within 4–6 hours after total thyroidectomy
— Earliest symptom: circumoral and acral paresthesias ("tingling around my lips and fingertips")
— Progression: muscle cramps → carpopedal spasm → tetany → laryngospasm, seizures, QT prolongation, torsades
— Hungry bone syndrome pattern: severe, prolonged hypocalcemia + hypophosphatemia + hypomagnesemia in patients with preop hyperthyroidism (Graves) or long-standing primary hyperparathyroidism who had concurrent parathyroidectomy
— Unilateral: hoarse, breathy voice, weak cough, choking on liquids (glottic incompetence), exercise intolerance
— Bilateral: inspiratory stridor and dyspnea immediately at extubation; voice may paradoxically sound nearly normal because cords sit in paramedian position
— Most "injuries" are neuropraxia from traction, recover within 6 months; if persistent >12 months, considered permanent
— Innervates cricothyroid muscle → tenses vocal cord for high pitch
— Subtle: vocal fatigue, inability to project, loss of upper register — often missed unless patient is a professional voice user
— Extent of surgery (total vs lobectomy, central neck dissection)
— Indication (Graves, cancer, large goiter)
— Intraoperative parathyroid identification/autotransplantation
— Preop vitamin D status, CKD, prior neck surgery or radiation
— Medications: PPIs (impair Ca absorption), loop diuretics, bisphosphonates, denosumab

— Inspect the neck incision for swelling, ecchymosis, drain output, tense fullness
— Palpate for firmness or tracheal deviation
— Listen for stridor (bilateral RLN injury or hematoma), assess work of breathing, pulse oximetry, ability to phonate full sentences
— Have the patient count to 10, sustain "eee," cough
— Breathy, weak voice → unilateral RLN
— Near-normal voice + stridor → think bilateral RLN paralysis
— Loss of high-pitch range without hoarseness → EBSLN injury
— Flexible fiberoptic laryngoscopy is the bedside confirmatory exam — order it for any voice/airway change
— Chvostek sign: tap facial nerve ~2 cm anterior to tragus → ipsilateral facial twitch (sensitive but ~10% of normals positive)
— Trousseau sign: BP cuff inflated 20 mm Hg above SBP for 3 min → carpal spasm (more specific)
— Hyperreflexia, perioral numbness, laryngospasm (stridor without nerve injury)
— Cardiac: bradycardia, prolonged QTc, hypotension; in severe cases, heart failure
— Tense, expanding neck swelling, drain suddenly filling with bright blood, voice change, dysphagia, anxiety, tracheal compression
— Do not wait for imaging — open the wound at bedside if airway is threatened

— Ionized calcium is the gold-standard measure; not affected by albumin
— If only total Ca available: corrected Ca = measured Ca + 0.8 × (4 – albumin g/dL)
— Check at 6–12 h postop and again at 24 h for total thyroidectomy; trend matters more than a single value
— Normal ionized Ca: 1.15–1.30 mmol/L; symptomatic typically <1.05 mmol/L or total Ca <8.0 mg/dL
— PTH <15 pg/mL (or <10) → high risk, start prophylactic calcium ± calcitriol
— PTH >15–20 pg/mL → low risk, can often discharge with as-needed calcium
— Hypomagnesemia (Mg <1.6 mg/dL) causes functional hypoparathyroidism and refractory hypocalcemia — always replete Mg before declaring calcium replacement a failure
— Phosphate elevated in true hypoparathyroidism; low phosphate suggests hungry bone syndrome
— Hypocalcemia → prolonged QT interval (risk of torsades)
— Order in any symptomatic patient or Ca <7.0 mg/dL

— Standard of care for any postoperative voice change, stridor, dysphagia, or aspiration
— Documents vocal cord position and mobility (paramedian = paralysis; bowing/atrophy = chronic)
— Preoperative FFL is recommended in patients with prior neck/chest surgery, voice complaints, invasive thyroid cancer, or retrosternal goiter to document baseline cord function — medicolegally critical
— Continuous or intermittent EMG of vagus/RLN; loss of signal predicts postop paresis
— On the exam, IONM is a quality measure, not a substitute for visual identification of the nerve
— Distinguishes neuropraxia (recovers) from denervation (permanent) in cords paralyzed >4–6 months
— Used by ENT to plan medialization vs reinnervation procedures
— CT or ultrasound of the neck for suspected hematoma, abscess, or seroma — only if patient is hemodynamically and airway stable
— MRI brain/skull base if RLN paralysis is found without clear surgical cause (rule out central or paraneoplastic lesion)
— Chest imaging if mediastinal extension or to evaluate left RLN course around the aortic arch
— PTH, 25-OH vitamin D, 1,25-OH vitamin D, 24-hour urinary calcium (to titrate calcitriol and avoid nephrocalcinosis)
— Persistent hypoparathyroidism despite apparently normal anatomy → consider autoimmune polyglandular syndrome type 1, DiGeorge (22q11.2), or activating CaSR mutations

— Low risk: hemithyroidectomy, PTH >15 pg/mL at 4 h, asymptomatic, normal Mg → routine oral calcium PRN, discharge POD#0–1
— Intermediate risk: total thyroidectomy with PTH 10–15, mild symptoms → scheduled oral calcium carbonate 1–2 g TID ± calcitriol 0.25–0.5 mcg BID
— High risk: PTH <10, central neck dissection, Graves, parathyroid autotransplantation, symptomatic, or Ca <7.5 → IV calcium gluconate + oral Ca + calcitriol; admit or observe 23 h
— Symptomatic (paresthesias, tetany, QT prolongation, seizure, laryngospasm) → IV calcium gluconate 1–2 g over 10–20 min, then infusion 0.5–1.5 mg elemental Ca/kg/h
— Asymptomatic mild (Ca 7.5–8.5) → oral calcium ± calcitriol
— Unilateral RLN paresis: voice therapy, observe 6–12 months for spontaneous recovery; if persistent and symptomatic, injection medialization (temporary) → type I thyroplasty (permanent)
— Bilateral RLN paralysis with stridor: emergent airway — reintubate or tracheostomy; later definitive options include cordotomy, arytenoidectomy, or reinnervation
— EBSLN injury: voice therapy; rarely requires surgery

— Calcium gluconate 1–2 g (10–20 mL of 10% solution) IV over 10–20 min via peripheral line — preferred peripherally because calcium chloride is sclerosing and reserved for central line/code situations
— Follow with infusion: 11 g calcium gluconate in 1 L D5W at 50–100 mL/h, titrate to ionized Ca 1.0–1.2 mmol/L
— Avoid bolus pushes — can cause bradyarrhythmias and cardiac arrest, especially in digoxin users
— Calcium carbonate 500–1000 mg elemental Ca TID with meals (needs gastric acid — less effective with PPIs)
— Calcium citrate preferred in patients on PPIs, post-bariatric, or achlorhydric
— Typical postop dose: 1–3 g elemental Ca/day divided
— Onset hours to days, bypasses renal 1α-hydroxylation (which requires PTH)
— Dose: 0.25–0.5 mcg PO BID, titrate to ionized Ca
— Monitor for hypercalciuria and nephrocalcinosis on chronic therapy
— Replete if Mg <1.8 mg/dL; IV Mg sulfate 1–2 g for symptomatic or refractory cases
— Without Mg repletion, calcium therapy will fail

— Remove skin staples/sutures and open the platysma at bedside to release the hematoma
— Apply pressure, secure airway, transport to OR for washout and definitive hemostasis
— Common bleeding sources: superior thyroid artery stump, middle thyroid vein, anterior jugular vein
— Immediate reintubation if stridor at extubation; if prolonged, tracheostomy
— Long-term definitive procedures (by ENT): endoscopic posterior cordotomy, partial arytenoidectomy, or laryngeal reinnervation — all trade voice quality for airway
— Temporary injection laryngoplasty (hyaluronic acid, carboxymethylcellulose, fat) within 3–12 months for symptomatic glottic incompetence
— Permanent medialization (type I thyroplasty) with Silastic or Gore-Tex implant after ~12 months without recovery
— Ansa cervicalis–to–RLN reinnervation restores tone but not movement
— Done intraoperatively when a parathyroid is inadvertently devascularized — gland is minced and implanted in sternocleidomastoid or forearm; functions in weeks to months
— Reduces but does not eliminate risk of permanent hypoparathyroidism
— Aim for low-normal Ca (8.0–8.5), normal PO₄, 24-h urine Ca <300 mg/day to avoid nephrocalcinosis
— Consider rhPTH(1-84) if requiring >2.5 g Ca and >1.5 mcg calcitriol daily

— Higher baseline rates of vitamin D deficiency, sarcopenia, and polypharmacy → higher risk of symptomatic hypocalcemia
— Falls risk from carpopedal spasm, hypocalcemic delirium, and QT-prolonging medications (haloperidol, ondansetron, quinolones — common postop)
— Lower threshold to admit for observation; start lower doses of calcitriol (0.25 mcg BID) and titrate
— Already have impaired 1α-hydroxylation of vitamin D → calcitriol is mandatory, not optional
— Preop secondary hyperparathyroidism with high bone turnover → marked risk of hungry bone syndrome postop
— Avoid phosphate binders containing calcium acutely (mask the picture); avoid magnesium-based products in advanced CKD
— Monitor for hyperphosphatemia in chronic hypoparathyroidism — may need non-Ca phosphate binders
— Time calcium repletion around dialysis sessions; dialysate calcium concentration is a tool
— Coordinate with nephrology before discharge
— Reduced 25-hydroxylation → consider calcifediol (25-OH-D) rather than cholecalciferol if available
— Coagulopathy raises hematoma risk — correct INR, platelets preoperatively
— Loop diuretics worsen hypocalcemia (urinary Ca wasting) — switch to thiazides if BP control allows
— Bisphosphonates and denosumab can precipitate severe, prolonged hypocalcemia after thyroidectomy — check Ca and vitamin D before any antiresorptive
— Digoxin + IV calcium → risk of "stone heart" arrhythmia; give calcium slowly with telemetry

— Thyroidectomy during pregnancy is reserved for compressive symptoms, suspected aggressive malignancy, or refractory hyperthyroidism intolerant of antithyroid drugs — optimally performed in the second trimester
— Maternal hypocalcemia → fetal hypocalcemia and neonatal tetany; maintain maternal ionized Ca in normal range
— Calcitriol and calcium carbonate are safe in pregnancy; thiazides used cautiously
— Postpartum: calcium requirements may rise during lactation; monitor closely
— Indications: medullary thyroid cancer in MEN2A/2B (prophylactic thyroidectomy in infancy/early childhood), Graves disease refractory to medical therapy, large goiter
— Higher complication rates than adults; should be done at high-volume pediatric endocrine centers
— Calcium needs are weight-based; calcitriol 0.01–0.05 mcg/kg/day
— Growth and cognitive development depend on adequate calcium and thyroid hormone replacement
— High rate of transient hypocalcemia due to hungry bone syndrome from preop hyperthyroid bone turnover
— Pretreat with antithyroid drugs and beta-blockers to render euthyroid; correct vitamin D deficiency preoperatively
— Watch for postoperative thyroid storm if not rendered euthyroid
— Markedly increased parathyroid devascularization risk
— Plan for routine parathyroid autotransplantation when glands cannot be preserved in situ
— Preop counseling about EBSLN and RLN risks is a documented informed-consent expectation
— Lower threshold for preop and postop laryngoscopy

— Life-threatening via venous congestion and laryngeal edema before tracheal compression
— Risk factors: hypertension, anticoagulation, Valsalva (vomiting, coughing), large goiter, Graves
— Mortality if airway lost ≈ 100%; bedside evacuation saves lives
— Chronic Ca + calcitriol → risk of nephrocalcinosis, nephrolithiasis, CKD, cataracts, basal ganglia calcifications, anxiety/depression
— Quality of life impact often underappreciated
— Unilateral: dysphonia, aspiration, pneumonia risk
— Bilateral: tracheostomy dependence or compromised airway/voice tradeoff

— Stridor, expanding neck hematoma, respiratory distress, oxygen desaturation
— Bilateral vocal cord paralysis at extubation
— Active surgical bleeding
— Symptomatic hypocalcemia with seizures, tetany, laryngospasm, or arrhythmia (prolonged QT, torsades)
— Requirement for continuous IV calcium infusion with telemetry
— Post-evacuation of cervical hematoma
— Postoperative thyroid storm
— Tracheostomy or reintubation for bilateral RLN injury
— Mildly symptomatic hypocalcemia on IV calcium infusion
— Ionized Ca <1.0 mmol/L even if asymptomatic
— Significant comorbidity (CAD, CKD, dig use)
— Endocrinology: refractory hypocalcemia, candidate for rhPTH, hungry bone syndrome, pregnancy
— Otolaryngology: any voice change or stridor → urgent FFL; long-term medialization planning
— Cardiology: QT prolongation, dig toxicity concern, hemodynamic instability
— Speech-language pathology: voice therapy, aspiration evaluation
— Anesthesia: difficult airway anticipation in reoperation, tracheomalacia
— Asymptomatic mild hypocalcemia (Ca 7.8–8.5) responding to oral calcium ± calcitriol
— Stable unilateral RLN paresis without aspiration
— Reliable patient with phone/transport access and 1-week follow-up secured

— Hypomagnesemia → functional PTH resistance; classic in alcohol use, diuretics, PPIs
— Hungry bone syndrome → high bone uptake post-Graves or post-parathyroidectomy; hypocalcemia + hypophosphatemia + normal PTH
— Massive transfusion (citrate chelation) → transient
— Acute pancreatitis (saponification) — uncommon but stem-worthy
— Sepsis with cytokine-driven hypocalcemia
— Rhabdomyolysis (early phase) — Ca deposits in damaged muscle
— Pseudohypocalcemia from low albumin → ionized Ca normal
— Postintubation laryngeal edema or arytenoid dislocation — resolves with time, steroids
— Cricoarytenoid joint fixation from intubation trauma
— Tracheomalacia after long-standing goiter removal
— Laryngospasm from hypocalcemia — distinguish by ionized Ca and symptom pattern
— Recurrent reflux laryngitis unmasking after surgery
— Pulmonary embolism, atelectasis, pneumonia for general dyspnea/hypoxia
— Seroma (soft, fluctuant, painless, late)
— Wound infection (POD#3–7, fever, erythema)
— Lymphocele/chyle leak after lateral neck dissection
— Subcutaneous emphysema if airway breached

— Vitamin D deficiency (chronic) — bony pain, proximal weakness, secondary hyperparathyroidism
— Pseudohypoparathyroidism — end-organ PTH resistance; high PTH, low Ca, Albright osteodystrophy features
— Autoimmune polyglandular syndrome type 1 (APECED) — hypoparathyroidism + adrenal insufficiency + mucocutaneous candidiasis
— DiGeorge syndrome (22q11.2) — congenital hypoparathyroidism, cardiac anomalies, T-cell deficiency
— Activating CaSR mutation (autosomal dominant hypocalcemia) — low Ca, inappropriately normal/low PTH, hypercalciuria
— Tumor lysis syndrome — hyperphosphatemia drives hypocalcemia
— Medications: bisphosphonates, denosumab, cinacalcet, foscarnet, cisplatin, aminoglycosides, PPIs
— Laryngeal carcinoma — smokers, persistent hoarseness >2–3 weeks, requires laryngoscopy
— GERD/laryngopharyngeal reflux
— Aortic arch aneurysm compressing left RLN (Ortner syndrome / cardiovocal syndrome)
— Apical lung tumor (Pancoast) with mediastinal extension
— Mediastinal lymphadenopathy (lymphoma, sarcoid, TB)
— Vocal cord nodules/polyps, muscle tension dysphonia
— Stroke affecting nucleus ambiguus, multiple sclerosis, Parkinson disease
— Anaphylaxis, angioedema (especially ACEi-related)
— Foreign body, epiglottitis, croup (pediatric)
— Tracheal stenosis from prior intubation

— Levothyroxine at 1.6 mcg/kg ideal body weight daily (lower in elderly/cardiac patients; TSH-suppressive doses for high-risk cancer per ATA risk stratification)
— Calcium carbonate 1–3 g elemental Ca daily, divided with meals (citrate if on PPI)
— Calcitriol 0.25–0.5 mcg BID if high-risk or symptomatic
— Cholecalciferol 1000–2000 IU daily for vitamin D stores
— Wound care instructions, return precautions for neck swelling, voice change, paresthesias, fever
— Call/return for tingling around mouth, hands, feet; muscle cramps; carpopedal spasm; new hoarseness; expanding neck swelling; fever
— Take calcium and levothyroxine at least 4 hours apart (calcium impairs T4 absorption)
— Take levothyroxine on empty stomach, 30–60 min before food/coffee
— Target ionized Ca low-normal, PO₄ normal, 24-h urine Ca <300 mg/day
— Annual renal ultrasound for nephrocalcinosis, ophthalmologic exam for cataracts
— Monitor renal function, eGFR; bone density if on chronic calcitriol
— rhPTH(1-84) for refractory/severe cases via endocrinology
— Voice therapy referral within 2–4 weeks
— Aspiration precautions, thickened liquids if dysphagia
— Reassess at 6 and 12 months; if no recovery, medialization
— TSH suppression per ATA risk category, thyroglobulin and anti-Tg antibodies q6–12 months, neck ultrasound

— POD#1–2: phone check or in-person; verify symptoms, calcium adherence
— 1–2 weeks: surgical wound check, voice assessment, repeat ionized Ca and Mg
— 4–6 weeks: TSH check; titrate levothyroxine; reassess calcium needs (often can wean)
— 3 months: PTH and Ca to confirm parathyroid recovery vs permanent hypoparathyroidism
— 6 and 12 months: for nerve injury, repeat laryngoscopy ± EMG; for cancer, thyroglobulin and neck ultrasound
— Calcium: ionized Ca preferred; total Ca with albumin acceptable; check q1–2 weeks during titration, then q3–6 months when stable
— Magnesium, phosphate: every visit during titration
— 24-h urine calcium: at 3 and 6 months on calcitriol, then annually
— TSH: 6 weeks after any levothyroxine dose change, then every 6–12 months
— Renal function and eGFR: annually
— DEXA: baseline and periodic in chronic hypoparathyroidism
— Voice therapy with SLP for any persistent dysphonia, ideally within 4 weeks
— Swallow study if aspiration suspected
— Diet: adequate dietary calcium (dairy, leafy greens, fortified foods); limit phosphate-rich processed foods in chronic hypoparathyroidism
— Activity: resume normal activity as tolerated; avoid heavy lifting for 1–2 weeks
— Driving: avoid until off opioids and voice/airway stable
— Psychological support: chronic hypocalcemia and dysphonia have measurable impact on quality of life and mood

— Risk of transient and permanent hypoparathyroidism with specific percentages
— Risk of RLN injury (voice change, aspiration) and bilateral RLN injury (tracheostomy)
— Risk of EBSLN injury, especially highlighted for professional voice users
— Risk of hematoma, infection, scar, need for lifelong thyroid hormone
— Alternatives discussed: radioactive iodine, antithyroid drugs, observation where appropriate
— Failure to document EBSLN/voice risks for a singer or teacher is a recurrent malpractice theme
— Indicated in prior neck surgery, voice changes, thyroid cancer, or substernal goiter — both medically and medicolegally protective; baseline cord function documentation prevents attribution disputes
— Same-day discharge after total thyroidectomy is feasible but requires structured patient education, reliable phone follow-up, and PTH-based risk stratification
— Missed hypocalcemia diagnosis after discharge is a common readmission and adverse event — explicit symptom teaching and 48-hour follow-up call are safety standards
— Medication reconciliation must clearly separate calcium/calcitriol vs levothyroxine timing to prevent malabsorption
— Outcomes are volume-dependent; high-volume surgeons (>25–50 thyroidectomies/year) have lower complication rates — relevant for referral decisions and shared decision-making
— If RLN injury or permanent hypoparathyroidism occurs, open and timely disclosure to the patient is required ethically and improves outcomes; refer to ENT/endocrinology promptly
— Adverse events meeting institutional thresholds should be reported through patient-safety event systems; aviation, commercial driving, and professional voice careers may require occupational health notification of voice/airway impairment

— Right RLN loops around right subclavian artery; left RLN loops around aortic arch (ligamentum arteriosum)
— Non-recurrent right RLN associated with aberrant right subclavian artery (arteria lusoria) — 0.5–1% incidence; high injury risk
— EBSLN innervates cricothyroid (voice pitch); travels with superior thyroid artery
— Parathyroids: superior glands from 4th pharyngeal pouch (more constant location, posterior to RLN); inferior glands from 3rd pouch (variable, anterior to RLN, may be in thymus)
— Chvostek: cheek tap → twitch (sensitive, less specific)
— Trousseau: cuff → carpal spasm (more specific)
— Hypocalcemia on ECG: prolonged QT, no U wave; severe → torsades
— Surgical hypoparathyroidism: ↓Ca, ↑PO₄, ↓PTH
— Hungry bone: ↓Ca, ↓PO₄, normal/↑PTH
— Vitamin D deficiency: ↓Ca, ↓PO₄, ↑PTH, ↓25-OH-D
— Pseudohypoparathyroidism: ↓Ca, ↑PO₄, ↑PTH
— Calcium gluconate over calcium chloride peripherally
— Calcium citrate if on PPI
— Thiazides reduce urinary Ca; loops increase it
— Denosumab/bisphosphonates → prolonged postop hypocalcemia
— Bilateral RLN paralysis = emergent airway, often tracheostomy
— Unilateral RLN: wait 6–12 months; medialize if persistent
— Parathyroid autotransplant into SCM or forearm
— Graves and renal hyperparathyroidism → hungry bone risk
— MEN2B: prophylactic thyroidectomy before age 1
— Pregnant: defer surgery if possible; second trimester if needed

— POD#1 after total thyroidectomy, tingling lips and fingers, positive Trousseau sign, Ca 7.2, ionized Ca 0.9, Mg 1.5 → Answer: IV calcium gluconate AND replete magnesium; start calcitriol; admit telemetry
— Despite IV calcium, Ca remains low → Answer: Check and replete magnesium
— Post-Graves total thyroidectomy with low Ca, low PO₄, normal PTH, prolonged need for high-dose Ca and calcitriol → Answer: Hungry bone syndrome; aggressive IV Ca, calcitriol, Mg, PO₄ repletion
— 4 h postop with neck swelling, stridor, dyspnea → Answer: Open wound at bedside, secure airway, OR for hemostasis; do not order CT first
— Immediately post-extubation stridor and respiratory distress with relatively preserved voice → Answer: Reintubate; FFL shows paramedian cords; plan tracheostomy if persistent
— POD#2 breathy voice, choking on water, FFL shows immobile cord → Answer: Voice therapy, observe 6–12 months; injection medialization if symptomatic; thyroplasty if permanent
— Singer after thyroidectomy cannot reach high notes, voice normal at conversational pitch → Answer: EBSLN injury (cricothyroid); voice therapy
— TSH checked 2 weeks postop and high → Answer: Wait until 6 weeks for steady state before adjusting dose
— Years post-thyroidectomy on Ca + calcitriol with nephrolithiasis → Answer: Add thiazide diuretic to reduce urinary calcium; check 24-h urine Ca; consider rhPTH

After thyroidectomy, your two career-defining complications are parathyroid-related hypocalcemia and laryngeal nerve injury — recognize them early with ionized calcium/PTH and bedside laryngoscopy, treat symptomatic hypocalcemia with IV calcium gluconate plus magnesium repletion and calcitriol, manage bilateral RLN injury as an airway emergency, and never delay bedside hematoma evacuation for imaging.
— Check ionized Ca, total Ca, albumin, Mg, PO₄, PTH at 6 h and 24 h
— Symptomatic or Ca <7.5 → IV calcium gluconate + Mg repletion + calcitriol + oral Ca
— Refractory → always check magnesium
— Distinguish surgical hypoparathyroidism (low PTH, high PO₄) from hungry bone (normal PTH, low PO₄)
— Any voice/airway change → flexible laryngoscopy
— Unilateral RLN → voice therapy, observe 6–12 months, then medialize if persistent
— Bilateral RLN → reintubate, tracheostomy, definitive cordotomy/arytenoidectomy later
— EBSLN → loss of high pitch in voice professionals; voice therapy
— Expanding cervical hematoma → open the wound at bedside, secure airway, OR — never wait for CT
— Levothyroxine 1.6 mcg/kg/day, TSH at 6 weeks, calcium/calcitriol weaned as parathyroids recover, endocrinology referral if hypoparathyroidism persists >6 months, ENT referral for unresolved nerve injury

